Acorda Therapeutics Inc
NASDAQ:ACOR
Acorda Therapeutics Inc
NASDAQ:ACOR
Price:
0.65 USD
-26.05%
Market Closed
Updated:
May 30, 2024
Acorda Therapeutics Inc
Non-Reccuring Items
|
Acorda Therapeutics Inc
Non-Reccuring Items Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Non-Reccuring Items Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Non-Reccuring Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Acorda Therapeutics Inc
NASDAQ:ACOR
|
Non-Reccuring Items
-$251.3m
|
CAGR 3-Years
-59%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Non-Reccuring Items
-$3.2B
|
CAGR 3-Years
-31%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Non-Reccuring Items
-$7.2B
|
CAGR 3-Years
-766%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Non-Reccuring Items
$10m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Non-Reccuring Items
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Non-Reccuring Items
-$137.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Acorda Therapeutics Inc's Non-Reccuring Items?
Non-Reccuring Items
-251.3m
USD
-251.3m
USD
Based on the financial report for Dec 31, 2023, Acorda Therapeutics Inc's Non-Reccuring Items amounts to -251.3m USD.
What is Acorda Therapeutics Inc's Non-Reccuring Items growth rate?
Non-Reccuring Items CAGR 3Y
-59%
-59%
The average annual Non-Reccuring Items growth rates for Acorda Therapeutics Inc have been -59% over the past three years .
You don't have any saved screeners yet
